Developmental Outcomes at 24 Months of Age in Toddlers Supplemented with Arachidonic Acid and Docosahexaenoic Acid: Results of a Double Blind Randomized, Controlled Trial

Developmental Outcomes at 24 Months of Age in Toddlers Supplemented with Arachidonic Acid and Docosahexaenoic Acid: Results of a Double Blind Randomized, Controlled Trial

Little is known about arachidonic acid (ARA) and docosahexaenoic acid (DHA) requirements in toddlers. A longitudinal, double blind, controlled trial in toddlers (n = 133) age 13.4 ± 0.9 months (mean ± standard deviation), randomized to receive a DHA (200 mg/day) and ARA (200 mg/day) supplement (supp...

Full description

Bibliographic Details
Main Authors: Angela M. Devlin, Cecil M. Y. Chau, Roger Dyer, Julie Matheson, Deanna McCarthy, Karin Yurko-Mauro, Sheila M. Innis, Ruth E. Grunau
Format: Article
Language:English
Published: MDPI AG 2017-09-01
Series:Nutrients
Subjects:
toddlers
long chain polyunsaturated fatty acids
arachidonic acid
docosahexaenoic acid
neurodevelopment
Online Access:https://www.mdpi.com/2072-6643/9/9/975

Internet

https://www.mdpi.com/2072-6643/9/9/975

Similar Items